Skip to main content
Clinical Trials/CTRI/2024/04/065710
CTRI/2024/04/065710Not yet recruitingNot Applicable

Outcome analysis of Total Hip Arthroplasty in Non-traumatic Avascular necrosis of femur head

Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha1 site in 1 country25 target enrollmentStarted: April 22, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
25
Locations
1
Primary Endpoint
At the end of study, there might be better

Study Overview

Brief Summary

Outcome analysis of Total Hip Replacement in Non-Traumatic Avascular Necrosis of Hip will be done. Patients will be evaluated on bases of Harris Hip score and on radiological parameters. 25 patients will be taken up for study. They would have gone Total Hip Replacement. Harris Hip score is a clinical assessment score,  whereas radiologicaly placement of acetabular cup, femoral head ans stem will be assesed.

Assessment will be done post operatively after 3, 6 and 12 months.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Operated cases of Total Hip Replacement in non-traumatic avascular necrosis of Femoral head.

Exclusion Criteria

  • Unwilling patients, cases of AVN of femoral head due to trauma, cases with pre-existing pelvic pathology, cases of pre-existing lower limb defects/deformities/limb length discrepancies.

Outcomes

Primary Outcomes

At the end of study, there might be better

Time Frame: 3 months, 6 months and 12 months

clinical outcome (using Harris Hip Score) in patients managed with Total Hip Arthroplasty.

Time Frame: 3 months, 6 months and 12 months

Secondary Outcomes

  • At the end of study, there might be better(radiological outcome in patients managed with Total Hip Arthroplasty.)

Investigators

Sponsor
Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Gursimran Singh

Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha

Study Sites (1)

Loading locations...

Similar Trials